The expression of the methylated DNA-binding protein MeCP2 increases during neuronal development, which suggests that this epigenetic factor is crucial for neuronal terminal differentiation. We evaluated dendritic and axonal development in embryonic day-18 hippocampal neurons in culture by measuring total length and counting branch point numbers at 4 days in vitro, well before synapse formation. Pyramidal neurons transfected with a plasmid encoding a small hairpin RNA (shRNA) to knockdown endogenous Mecp2 had shorter dendrites than control untransfected neurons, without detectable changes in axonal morphology. On the other hand, overexpression of wildtype (wt) human MECP2 increased dendritic branching, in addition to axonal branching and length. Consistent with reduced neuronal growth and complexity in Rett syndrome (RTT) brains, overexpression of human MECP2 carrying missense mutations common in RTT individuals (R106W or T158M) reduced dendritic and axonal length. One of the targets of MeCP2 transcriptional control is the Bdnf gene. Indeed, endogenous Mecp2 knockdown increased the intracellular levels of BDNF protein compared to untransfected neurons, suggesting that MeCP2 represses Bdnf transcription. Surprisingly, overexpression of wt MECP2 also increased BDNF levels, while overexpression of RTT-associated MECP2 mutants failed to affect BDNF levels. The extracellular BDNF scavenger TrkB-Fc prevented dendritic overgrowth in wt MECP2-overexpressing neurons, while overexpression of the Bdnf gene reverted the dendritic atrophy caused by Mecp2-knockdown. However, this effect was only partial, since Bdnf increased dendritic length only to control levels in mutant MECP2-overexpressing neurons, but not as much as in Bdnf-transfected cells. Our results demonstrate that MeCP2 plays varied roles in dendritic and axonal development during neuronal terminal differentiation, and that some of these effects are mediated by autocrine actions of BDNF.
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Introduction
Neurodevelopmental disorders caused by genetic disruptions or chemical/physical insults during brain development affect neuronal terminal differentiation, i.e. axon and dendrite growth and branching, as well as synaptogenesis, thus impairing synaptic transmission and plasticity leading to altered network connectivity (Chechlacz and Gleeson, 2003; Johnston et al., 2001) . Reduced dendritic length and branching have been demonstrated in many disorders associated with mental retardation (Kaufmann and Moser, 2000) . One disorder associated with impaired brain development is Rett syndrome (RTT), a disease that affects nearly 1:15,000 females worldwide (Hagberg et al., 1985) . Early development appears normal in individuals with RTT until approximately 6-18 months of age, when physical, motor and social-cognitive behavior enter a period of regression (Hagberg, 2002; Percy and Lane, 2005) . Indeed, the neuropathology of RTT reveals several areas of abnormal brain development. Head circumference is decelerated, and postmortem observations of RTT brains demonstrate a reduction in brain weight (Armstrong et al., 1999; Jellinger et al., 1988; Schultz et al., 1993) . Microscopically, brain autopsy material from RTT patients revealed impaired dendritic growth and complexity of pyramidal cells in the frontal and motor cortices, as well as in the subiculum (Armstrong et al., 1995) , and reduced levels of MAP-2, a dendritic protein involved in microtubule stabilization (Kaufmann et al., 2000; Kaufmann et al., 1995 Kaufmann et al., , 1997 . These observations support the notion that RTT is a disorder caused by impaired dendritic, axonal and eventually synapse formation and maturation, leaving afflicted individuals in a state of arrested brain development (Armstrong, 2002; Johnston et al., 2001 Johnston et al., , 2003 Kaufmann et al., 2005; LaSalle, 2004; Naidu, 1997; Philippart, 2001 ). E-mail address: lucaspm@uab.edu (L. Pozzo-Miller). 1 JLL and CAC contributed equally to this work.
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